121 related articles for article (PubMed ID: 17576056)
1. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery.
Amidi M; Pellikaan HC; de Boer AH; Crommelin DJ; Hennink WE; Jiskoot W
Eur J Pharm Biopharm; 2008 Feb; 68(2):191-200. PubMed ID: 17576056
[TBL] [Abstract][Full Text] [Related]
2. Formulation of insulin-loaded N-trimethyl chitosan microparticles with improved efficacy for inhalation by supercritical fluid assisted atomization.
Shen YB; Du Z; Tang C; Guan YX; Yao SJ
Int J Pharm; 2016 May; 505(1-2):223-33. PubMed ID: 27034000
[TBL] [Abstract][Full Text] [Related]
3. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs.
Amidi M; Pellikaan HC; Hirschberg H; de Boer AH; Crommelin DJ; Hennink WE; Kersten G; Jiskoot W
Vaccine; 2007 Sep; 25(37-38):6818-29. PubMed ID: 17692440
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulated chitosan nanoparticles for lung protein delivery.
Grenha A; Seijo B; Remuñán-López C
Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
[TBL] [Abstract][Full Text] [Related]
5. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
You Y; Zhao M; Liu G; Tang X
J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
[TBL] [Abstract][Full Text] [Related]
6. Preparation of zolmitriptan-chitosan microparticles by spray drying for nasal delivery.
Alhalaweh A; Andersson S; Velaga SP
Eur J Pharm Sci; 2009 Oct; 38(3):206-14. PubMed ID: 19616094
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs.
Ungaro F; De Rosa G; Miro A; Quaglia F; La Rotonda MI
Eur J Pharm Sci; 2006 Aug; 28(5):423-32. PubMed ID: 16806857
[TBL] [Abstract][Full Text] [Related]
8. Insulin-micro- and nanoparticles for pulmonary delivery.
Klingler C; Müller BW; Steckel H
Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing.
Irngartinger M; Camuglia V; Damm M; Goede J; Frijlink HW
Eur J Pharm Biopharm; 2004 Jul; 58(1):7-14. PubMed ID: 15207532
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
Learoyd TP; Burrows JL; French E; Seville PC
Eur J Pharm Biopharm; 2008 Feb; 68(2):224-34. PubMed ID: 17560772
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
Pilcer G; Vanderbist F; Amighi K
Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
[TBL] [Abstract][Full Text] [Related]
12. Stable sugar-based protein formulations by supercritical fluid drying.
Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851
[TBL] [Abstract][Full Text] [Related]
13. Development of a spray congealing process for the preparation of insulin-loaded lipid microparticles and characterization thereof.
Maschke A; Becker C; Eyrich D; Kiermaier J; Blunk T; Göpferich A
Eur J Pharm Biopharm; 2007 Feb; 65(2):175-87. PubMed ID: 17070025
[TBL] [Abstract][Full Text] [Related]
14. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
15. Formulation and in vitro evaluation of highly dispersive insulin dry powder formulations for lung administration.
Depreter F; Amighi K
Eur J Pharm Biopharm; 2010 Nov; 76(3):454-63. PubMed ID: 20797437
[TBL] [Abstract][Full Text] [Related]
16. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pulmonary insulin delivery in diabetic rats: use of a model-based approach in the evaluation of insulin powder formulations.
Amidi M; Krudys KM; Snel CJ; Crommelin DJ; Della Pasqua OE; Hennink WE; Jiskoot W
J Control Release; 2008 May; 127(3):257-66. PubMed ID: 18353483
[TBL] [Abstract][Full Text] [Related]
18. Polymethacrylate based microparticulates of insulin for oral delivery, part II: solid state characterization.
Agarwal V; Khan MA; Nazzal S
Pharmazie; 2008 Feb; 63(2):122-8. PubMed ID: 18380398
[TBL] [Abstract][Full Text] [Related]
19. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
Grenha A; Remuñán-López C; Carvalho EL; Seijo B
Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
